Does DABRAFENIB Cause Product dose omission issue? 93 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Product dose omission issue have been filed in association with DABRAFENIB (Tafinlar). This represents 0.5% of all adverse event reports for DABRAFENIB.
93
Reports of Product dose omission issue with DABRAFENIB
0.5%
of all DABRAFENIB reports
4
Deaths
20
Hospitalizations
How Dangerous Is Product dose omission issue From DABRAFENIB?
Of the 93 reports, 4 (4.3%) resulted in death, 20 (21.5%) required hospitalization, and 3 (3.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 93 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DABRAFENIB Alternatives Have Lower Product dose omission issue Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB